Immunotoxin - PDFSEARCH.IO - Document Search Engine

Immunotoxin
Results: 15

#	Item
1	November 12, 2014 Dear Colleagues, Please find below details of a high priority clinical study just opened to patient accrual at the Northwestern Medicine Developmental Therapeutics Institute (NMDTI). A Pivotal Multicent Add to Reading List Source URL: dti.nm.org Language: English - Date: 2014-11-12 14:34:06 Orphan drugs Organochlorides Purines Immunotoxin Pentostatin Leukemia CD22 Cladribine Chemistry Lymphocytic leukemia Hairy cell leukemia Biology
2	Anti-PSMA Immunotoxins Novel Targeted Therapeutics for Prostate Cancer Technology The Prostate Specific Membrane Antigen (PSMA) has been proven to be an excellent target for prostate cancer therapy. It is highly expresse Add to Reading List Source URL: www.campus-technologies.de Language: English - Date: 2014-11-10 10:17:25 Urology Tumor markers Prostate-specific membrane antigen PC3 Prostate cancer Immunotoxin DU145 Immunotherapy Medicine Cancer research Cell lines
3	Anti-PSMA Immunotoxins Novel Targeted Therapeutics for Prostate Cancer Albert-Ludwigs-Universität Freiburg Technology The Prostate Specific Membrane Antigen (PSMA) has been proven to be an excellent target for prostate Add to Reading List Source URL: www.zft.uni-freiburg.de Language: English - Date: 2011-06-06 07:53:00 Urology Tumor markers Prostate-specific membrane antigen PC3 Prostate cancer Immunotoxin DU145 Immunotherapy Medicine Cancer research Cell lines
4	A Better Immunotoxin Through inspired engineering, proteins that enter and kill cancer cells are finding their place among cancer treatments. (Photo: R. Baer) Add to Reading List Source URL: home.ccr.cancer.gov Language: English - Date: 2010-07-09 15:00:30 Anti-CD22 immunotoxin Hematology Cancer treatments Ira Pastan Immune system Hairy cell leukemia Immunotoxin Mesothelin Management of cancer Medicine Biology Lymphocytic leukemia
5	OBA Protocol[removed]MSKCC IRB[removed]Phase I study of In Vitro expanded allogeneic Epstein-Barr Virus specific Cytotoxic T-Lymphocytes (EBV-CTLs) genetically targeted to B cell specific antigen CD 19 positive for In Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 12:39:20 Complement receptor 2 Complement system Epstein–Barr virus Chimeric antigen receptor CD19 Hematopoietic stem cell transplantation Leukemia Anti-CD19 immunotoxin Medicine Anatomy Biology
6	f e a t u r e Precision in Targeting with Anti-Mesothelin Therapies For two decades, Raffit Hassan, M.D., Co-Chief of CCR’s Thoracic and Gastrointestinal Oncology Add to Reading List Source URL: home.ccr.cancer.gov Language: English - Date: 2014-07-08 18:13:38 Mesothelin Proteins Mesothelioma Ira Pastan Cancer vaccine Management of cancer Chemotherapy Anti-CD22 immunotoxin Medicine Health Cancer treatments
7	VB6-845 Licensing Opportunity VIVENTIA Bio Inc. VB6-845 Add to Reading List Source URL: www.viventia.com Language: English - Date: 2013-03-14 08:27:59 Oncology Immune system Epithelial cell adhesion molecule Cancer treatments Antibody-drug conjugate Bi-specific T-cell engager Cancer stem cell Chemotherapy Immunotoxin Medicine Biology Monoclonal antibodies
8	f e a t u r e Precision in Targeting with Anti-Mesothelin Therapies For two decades, Raffit Hassan, M.D., Co-Chief of CCR’s Thoracic and Gastrointestinal Oncology Add to Reading List Source URL: home.ccr.cancer.gov Language: English - Date: 2014-06-26 13:56:08 Mesothelin Proteins Mesothelioma Ira Pastan Cancer vaccine Management of cancer Chemotherapy Anti-CD22 immunotoxin Medicine Health Cancer treatments
9	Fusogenics™: A novel approach to antibody affinity maturation Add to Reading List Source URL: www.viventia.com Language: English - Date: 2013-03-14 08:27:25 Affinity maturation Fusion protein Hybridoma technology Immunotoxin Single-domain antibody Immune system Biology Antibody
10	A preclinical profile of VB6-845: a recombinant immunotoxin for targeting ovarian cancer Add to Reading List Source URL: www.viventia.com Language: English - Date: 2013-03-14 08:26:09 Gynaecological cancer Ovarian cancer Carcinoma

UPDATE